External broker reports(aggregated public sources), Axis Direct

Axis Direct

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only.  Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

Max Healthcare Institute / Equity Bottom-Up

<ul><li>Strong Revenue Growth Driven by New Hospitals: Max Healthcare reported revenue of Rs 2,326 Cr, in line with expectations, supported by steady ARPOB and contributions from new hospitals, despite a marginal drop in occupancy. </li><li>Stable ARPOB and Improved Occupancy: ARPOB stood at Rs 77,100, remaining flat YoY (Existing units +7% Growth YoY), while occupancy improved to 75% (up 300 bps YoY on a like-to-like basis), driven by a 30% YoY growth in occupied bed days. </li><li>EBITDA Margins and Profitability: EBITDA margins remained stable at 26.4% over the year, despite the addition of new assets. </li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Strong Revenue Growth Driven by New Hospitals: Max Healthcare reported revenue of Rs 2,326 Cr, in line with expectations, supported by steady ARPOB and contributions from new hospitals, despite a marginal drop in occupancy. Stable ARPOB and Improved Occupancy: ARPOB stood at Rs 77,100, remaining flat YoY (Existing units +7% Growth YoY), while occupancy improved to 75% (up 300 bps YoY on a like-to-like basis), driven by a 30% YoY growth in occupied bed days. EBITDA Margins and Profitability: EBITDA margins remained stable at 26.4% over the year, despite the addition of new assets. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Max Healthcare Institute Ltd - Expansion Accelerates; Profitability Strengthened